{"id":2397,"date":"2025-09-10T18:19:08","date_gmt":"2025-09-10T18:19:08","guid":{"rendered":"https:\/\/transcom-pharma.com\/en\/?page_id=2397"},"modified":"2025-09-10T18:30:21","modified_gmt":"2025-09-10T18:30:21","slug":"press-release-regarding-the-start-of-the-project","status":"publish","type":"page","link":"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/","title":{"rendered":"Press release"},"content":{"rendered":"<p>[vc_row][vc_column][vc_column_text]<\/p>\n<h1 style=\"text-align: center;\" data-start=\"132\" data-end=\"180\"><strong data-start=\"132\" data-end=\"178\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-2388\" src=\"https:\/\/transcom-pharma.com\/en\/wp-content\/uploads\/2025\/09\/1.jpg\" alt=\"\" width=\"929\" height=\"127\" srcset=\"https:\/\/transcom-pharma.com\/en\/wp-content\/uploads\/2025\/09\/1.jpg 929w, https:\/\/transcom-pharma.com\/en\/wp-content\/uploads\/2025\/09\/1-300x41.jpg 300w, https:\/\/transcom-pharma.com\/en\/wp-content\/uploads\/2025\/09\/1-768x105.jpg 768w, https:\/\/transcom-pharma.com\/en\/wp-content\/uploads\/2025\/09\/1-370x51.jpg 370w, https:\/\/transcom-pharma.com\/en\/wp-content\/uploads\/2025\/09\/1-360x49.jpg 360w\" sizes=\"auto, (max-width: 929px) 100vw, 929px\" \/><\/strong><\/h1>\n<p style=\"text-align: right;\" data-start=\"132\" data-end=\"180\"><strong><em>Date: 04 August 2025, Location: Stefanesti City<\/em><\/strong><\/p>\n<h1 style=\"text-align: center;\" data-start=\"132\" data-end=\"180\"><strong data-start=\"132\" data-end=\"178\">Press Release on the Launch of the Project<\/strong><\/h1>\n<p data-start=\"182\" data-end=\"631\">Transcom Danmar SRL, tax identification code 30560409, registered with the Trade Register under no. J3\/1128\/2012, headquartered at Strada Drago\u0219 Vod\u0103, No. 8, Pite\u0219ti, Arge\u0219 County, Romania, announces the start of the project entitled <em data-start=\"416\" data-end=\"500\">\u201cIntensification of Sustainable Growth and Competitiveness of Transcom Danmar SRL\u201d<\/em>, SMIS code 329434, co-financed by the European Regional Development Fund, through the South-Muntenia Regional Program 2021\u20132027.<\/p>\n<p data-start=\"633\" data-end=\"1073\"><strong data-start=\"633\" data-end=\"646\">Priority:<\/strong> P1. A competitive region through innovation, digitalization, and dynamic enterprises<br data-start=\"731\" data-end=\"734\" \/><strong data-start=\"734\" data-end=\"757\">Specific Objective:<\/strong> RSO1.3_ Intensification of sustainable growth and competitiveness of SMEs and job creation within SMEs, including through productive investments<br data-start=\"902\" data-end=\"905\" \/><strong data-start=\"905\" data-end=\"914\">Call:<\/strong> Intensification of sustainable growth and competitiveness of micro-enterprises, small enterprises, and medium-sized enterprises in the South-Muntenia region<\/p>\n<p data-start=\"1075\" data-end=\"1847\"><strong data-start=\"1075\" data-end=\"1091\">Beneficiary:<\/strong> Transcom Danmar SRL<br data-start=\"1111\" data-end=\"1114\" \/><strong data-start=\"1114\" data-end=\"1132\">Project title:<\/strong> <em data-start=\"1133\" data-end=\"1217\">\u201cIntensification of Sustainable Growth and Competitiveness of Transcom Danmar SRL\u201d<\/em><br data-start=\"1217\" data-end=\"1220\" \/><strong data-start=\"1220\" data-end=\"1232\">Program:<\/strong> South-Muntenia Regional Program 2021\u20132027<br data-start=\"1274\" data-end=\"1277\" \/><strong data-start=\"1277\" data-end=\"1316\">Priority, Specific Objective, Call:<\/strong> P1. A competitive region through innovation, digitalization, and dynamic enterprises; RSO1.3_ Intensification of sustainable growth and competitiveness of SMEs and job creation within SMEs, including through productive investments; Intensification of sustainable growth and competitiveness of micro-enterprises, small enterprises, and medium-sized enterprises in the South-Muntenia region<br data-start=\"1705\" data-end=\"1708\" \/><strong data-start=\"1708\" data-end=\"1722\">SMIS code:<\/strong> 329434<br data-start=\"1729\" data-end=\"1732\" \/><strong data-start=\"1732\" data-end=\"1764\">Location (County, Locality):<\/strong> \u0218tef\u0103ne\u0219ti City, \u201cBunescu \u2013 La Sticle\u201d Point, Plot 27, Parcel 1559, Arge\u0219 County<\/p>\n<p data-start=\"1849\" data-end=\"2371\"><strong data-start=\"1849\" data-end=\"1871\">General Objective:<\/strong><br data-start=\"1871\" data-end=\"1874\" \/>The main objective of the project is to intensify sustainable growth and increase the competitiveness of the applicant, through non-reimbursable financial aid granted as de minimis aid for investments. The implementation of this project contributes to creating a favorable environment for the company\u2019s development, specific to its field of activity \u2013 technical testing and analysis activities, to creating new jobs within the company, and, not least, to increasing its economic competitiveness.<\/p>\n<p data-start=\"2373\" data-end=\"2399\"><strong data-start=\"2373\" data-end=\"2397\">Specific Objectives:<\/strong><\/p>\n<ul data-start=\"2400\" data-end=\"3026\">\n<li data-start=\"2400\" data-end=\"2713\">\n<p data-start=\"2402\" data-end=\"2713\"><strong data-start=\"2402\" data-end=\"2426\">Specific Objective 1<\/strong> \u2013 Construction works for a building \u2013 administrative and service space (ground floor with high ceiling + partial first floor), and equipping it with modern equipment necessary for carrying out the activity, in accordance with CAEN code 4520 \u2013 Maintenance and repair of motor vehicles.<\/p>\n<\/li>\n<li data-start=\"2714\" data-end=\"2911\">\n<p data-start=\"2716\" data-end=\"2911\"><strong data-start=\"2716\" data-end=\"2740\">Specific Objective 2<\/strong> \u2013 Use of renewable energy sources to increase efficiency in the activity for which financing is requested, within the limit of 15% of the eligible value of the project.<\/p>\n<\/li>\n<li data-start=\"2912\" data-end=\"3026\">\n<p data-start=\"2914\" data-end=\"3026\"><strong data-start=\"2914\" data-end=\"2938\">Specific Objective 3<\/strong> \u2013 Increase in sales volume compared to 2023, by promoting new services on the market.<\/p>\n<\/li>\n<\/ul>\n<p data-start=\"3028\" data-end=\"3546\"><strong data-start=\"3028\" data-end=\"3079\">Project purpose and expected or actual results:<\/strong><br data-start=\"3079\" data-end=\"3082\" \/>Carrying out construction works \u2013 administrative and service space (ground floor with high ceiling + partial first floor), and equipping it with modern equipment necessary for carrying out the activity, in accordance with CAEN code 4520 \u2013 Maintenance and repair of motor vehicles, as well as the use of renewable energy sources to increase efficiency in the activity for which financing is requested, within the limit of 15% of the eligible value of the project.<\/p>\n<p data-start=\"3548\" data-end=\"3727\"><strong data-start=\"3548\" data-end=\"3572\">Start and End Dates:<\/strong> 07\/2025 \u2013 07\/2028<br data-start=\"3590\" data-end=\"3593\" \/><strong data-start=\"3593\" data-end=\"3610\">Total budget:<\/strong> \u20ac972,217.34<br data-start=\"3622\" data-end=\"3625\" \/><strong data-start=\"3625\" data-end=\"3639\">EU budget:<\/strong> \u20ac423,690.73<br data-start=\"3651\" data-end=\"3654\" \/><strong data-start=\"3654\" data-end=\"3674\">National budget:<\/strong> \u20ac74,768.95<br data-start=\"3685\" data-end=\"3688\" \/><strong data-start=\"3688\" data-end=\"3713\">Beneficiary\u2019s budget:<\/strong> \u20ac473,757.66<\/p>\n<p data-start=\"3729\" data-end=\"3802\"><strong data-start=\"3729\" data-end=\"3749\">Contact details:<\/strong> <a class=\"decorated-link cursor-pointer\" rel=\"noopener\" data-start=\"3750\" data-end=\"3783\"><span \n                data-original-string=\"66SWG3HWtG0jRQ8ynQCpTg==55eeNJdAv3YSJ0L61YBg0T8uiGQDfFqmqXMh1YiYOUcY706QO+LJT25yJZKaFJULlb7\"\n                class=\"apbct-email-encoder\"\n                title=\"This contact has been encoded by Anti-Spam by CleanTalk. Click to decode. To finish the decoding make sure that JavaScript is enabled in your browser.\">co<span class=\"apbct-blur\">***********@tr*************.c<\/span>om<\/span><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-2779 aligncenter\" src=\"https:\/\/transcom-pharma.com\/wp-content\/uploads\/2025\/08\/2.jpg\" alt=\"\" width=\"762\" height=\"43\" \/>[\/vc_column_text][vc_empty_space height=&#8221;20px&#8221;][\/vc_column][\/vc_row][vc_row css=&#8221;.vc_custom_1418301066256{padding-top: 80px !important;padding-bottom: 30px !important;}&#8221; has_content=&#8221;true&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;2165&#8243; img_size=&#8221;medium&#8221;][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_column_text]<\/p>\n<div>Transcom Danmar SRL<\/div>\n<div>RO30560409<\/div>\n<div>J03\/1128\/2012<\/div>\n<div><\/div>\n<div><\/div>\n<div id=\"anpstext-9\" class=\"widget-container widget_anpstext\">Adresa: Str.Garii nr 23 A, Pitesti, Jud. Arges &#8211; 110188<\/div>\n<div id=\"anpstext-10\" class=\"widget-container widget_anpstext\"><a href=\"tel:+40 741 792 723\">+40 741 792 723<\/a><\/div>\n<div id=\"anpstext-11\" class=\"widget-container widget_anpstext\"><a href=\"tel:+40 348 410 049\">+40 348 410 049<\/a><\/div>\n<div id=\"anpstext-12\" class=\"widget-container widget_anpstext\"><a href=\"mailto:co*****@tr*************.com\" data-original-string=\"\/jPxkuudu2WU7zqaTpALWQ==55eDgi6wtzTY0AMizCpQVDRwvcxPB5g+Ine1rAXneW2fPM=\" title=\"This contact has been encoded by Anti-Spam by CleanTalk. Click to decode. To finish the decoding make sure that JavaScript is enabled in your browser.\"><span \n                data-original-string=\"4p\/5CIN\/anyRzjnLotaS5Q==55eXpkS56AJNDpuVcc9tW5F2Bk2m5PZkxjC3sDXvZ\/30CM=\"\n                class=\"apbct-email-encoder\"\n                title=\"This contact has been encoded by Anti-Spam by CleanTalk. Click to decode. To finish the decoding make sure that JavaScript is enabled in your browser.\">co<span class=\"apbct-blur\">*****@tr*************.c<\/span>om<\/span><\/a><\/div>\n<p>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text] Date: 04 August 2025, Location: Stefanesti City Press Release on the Launch of the Project Transcom Danmar SRL, tax identification code 30560409, registered with the Trade Register under no. J3\/1128\/2012, headquartered at Strada Drago\u0219 Vod\u0103, No. 8, Pite\u0219ti, Arge\u0219&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2397","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Press release<\/title>\n<meta name=\"description\" content=\"The main objective of the project is to enhance sustainable growth and increase the applicant&#039;s competitiveness, through non-refundable financial aid granted in the form of de minimis aid through investments.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Press release\" \/>\n<meta property=\"og:description\" content=\"The main objective of the project is to enhance sustainable growth and increase the applicant&#039;s competitiveness, through non-refundable financial aid granted in the form of de minimis aid through investments.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Express\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-10T18:30:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/transcom-pharma.com\/en\/wp-content\/uploads\/2025\/09\/1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"929\" \/>\n\t<meta property=\"og:image:height\" content=\"127\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/\",\"url\":\"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/\",\"name\":\"Press release\",\"isPartOf\":{\"@id\":\"https:\/\/transcom-pharma.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/transcom-pharma.com\/en\/wp-content\/uploads\/2025\/09\/1.jpg\",\"datePublished\":\"2025-09-10T18:19:08+00:00\",\"dateModified\":\"2025-09-10T18:30:21+00:00\",\"description\":\"The main objective of the project is to enhance sustainable growth and increase the applicant's competitiveness, through non-refundable financial aid granted in the form of de minimis aid through investments.\",\"breadcrumb\":{\"@id\":\"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/#primaryimage\",\"url\":\"https:\/\/transcom-pharma.com\/en\/wp-content\/uploads\/2025\/09\/1.jpg\",\"contentUrl\":\"https:\/\/transcom-pharma.com\/en\/wp-content\/uploads\/2025\/09\/1.jpg\",\"width\":929,\"height\":127},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/transcom-pharma.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Press release\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/transcom-pharma.com\/en\/#website\",\"url\":\"https:\/\/transcom-pharma.com\/en\/\",\"name\":\"Transcom Pharma\",\"description\":\"Pharma Express\",\"publisher\":{\"@id\":\"https:\/\/transcom-pharma.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/transcom-pharma.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/transcom-pharma.com\/en\/#organization\",\"name\":\"Pharma Express\",\"url\":\"https:\/\/transcom-pharma.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/transcom-pharma.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/transcom-pharma.com\/en\/wp-content\/uploads\/2022\/07\/Logo-1024x408.png\",\"contentUrl\":\"https:\/\/transcom-pharma.com\/en\/wp-content\/uploads\/2022\/07\/Logo-1024x408.png\",\"width\":1024,\"height\":408,\"caption\":\"Pharma Express\"},\"image\":{\"@id\":\"https:\/\/transcom-pharma.com\/en\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Press release","description":"The main objective of the project is to enhance sustainable growth and increase the applicant's competitiveness, through non-refundable financial aid granted in the form of de minimis aid through investments.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/","og_locale":"en_US","og_type":"article","og_title":"Press release","og_description":"The main objective of the project is to enhance sustainable growth and increase the applicant's competitiveness, through non-refundable financial aid granted in the form of de minimis aid through investments.","og_url":"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/","og_site_name":"Pharma Express","article_modified_time":"2025-09-10T18:30:21+00:00","og_image":[{"width":929,"height":127,"url":"https:\/\/transcom-pharma.com\/en\/wp-content\/uploads\/2025\/09\/1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/","url":"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/","name":"Press release","isPartOf":{"@id":"https:\/\/transcom-pharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/#primaryimage"},"image":{"@id":"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/#primaryimage"},"thumbnailUrl":"https:\/\/transcom-pharma.com\/en\/wp-content\/uploads\/2025\/09\/1.jpg","datePublished":"2025-09-10T18:19:08+00:00","dateModified":"2025-09-10T18:30:21+00:00","description":"The main objective of the project is to enhance sustainable growth and increase the applicant's competitiveness, through non-refundable financial aid granted in the form of de minimis aid through investments.","breadcrumb":{"@id":"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/#primaryimage","url":"https:\/\/transcom-pharma.com\/en\/wp-content\/uploads\/2025\/09\/1.jpg","contentUrl":"https:\/\/transcom-pharma.com\/en\/wp-content\/uploads\/2025\/09\/1.jpg","width":929,"height":127},{"@type":"BreadcrumbList","@id":"https:\/\/transcom-pharma.com\/en\/press-release-regarding-the-start-of-the-project\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transcom-pharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"Press release"}]},{"@type":"WebSite","@id":"https:\/\/transcom-pharma.com\/en\/#website","url":"https:\/\/transcom-pharma.com\/en\/","name":"Transcom Pharma","description":"Pharma Express","publisher":{"@id":"https:\/\/transcom-pharma.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transcom-pharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/transcom-pharma.com\/en\/#organization","name":"Pharma Express","url":"https:\/\/transcom-pharma.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transcom-pharma.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/transcom-pharma.com\/en\/wp-content\/uploads\/2022\/07\/Logo-1024x408.png","contentUrl":"https:\/\/transcom-pharma.com\/en\/wp-content\/uploads\/2022\/07\/Logo-1024x408.png","width":1024,"height":408,"caption":"Pharma Express"},"image":{"@id":"https:\/\/transcom-pharma.com\/en\/#\/schema\/logo\/image\/"}}]}},"jetpack_sharing_enabled":true,"jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/transcom-pharma.com\/en\/wp-json\/wp\/v2\/pages\/2397","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transcom-pharma.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/transcom-pharma.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/transcom-pharma.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/transcom-pharma.com\/en\/wp-json\/wp\/v2\/comments?post=2397"}],"version-history":[{"count":5,"href":"https:\/\/transcom-pharma.com\/en\/wp-json\/wp\/v2\/pages\/2397\/revisions"}],"predecessor-version":[{"id":2399,"href":"https:\/\/transcom-pharma.com\/en\/wp-json\/wp\/v2\/pages\/2397\/revisions\/2399"}],"wp:attachment":[{"href":"https:\/\/transcom-pharma.com\/en\/wp-json\/wp\/v2\/media?parent=2397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}